COMMUNIQUÉS West-GlobeNewswire

Shire plc : Director/PDMR Shareholding

03/05/2018 - 14:01

Director/PDMR Shareholding May 3, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company") Notification of transactions by person discharging managerial responsibilities 1. Details of the person discharging managerial [...]

Iovance Biotherapeutics to Host First Quarter 2018 Financial Results Conference Call and Webcast on Thursday, May 10, 2018

03/05/2018 - 14:01

SAN CARLOS, Calif., May 03, 2018 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA ), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology [...]

Evolus to Present at the Bank of America Merrill Lynch 2018 Health Care Conference

03/05/2018 - 14:01

IRVINE, Calif., May 03, 2018 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS ) (“Evolus”), a lifestyle aesthetics company focused on delivering advanced aesthetic procedures and treatments to physicians and consumers, [...]

Five million doses of Prevtec Microbia’s bivalent vaccine Coliprotec® F4/F18 Sold in the European Union

03/05/2018 - 14:00

MONTREAL, May 03, 2018 (GLOBE NEWSWIRE) -- Prevtec Microbia Inc. (“Prevtec”) is pleased to announce that five million doses of its bivalent vaccine Coliprotec® F4/F18 have been sold in the European Union (EU) since its [...]

Prevtec Microbia atteint le seuil de cinq millions de doses vendues en Union Européenne pour son vaccin bivalent Coliprotec® F4/F18

03/05/2018 - 14:00

MONTRÉAL, 03 mai 2018 (GLOBE NEWSWIRE) -- Prevtec Microbia Inc. (« Prevtec ») a le plaisir d’annoncer que son vaccin bivalent Coliprotec® F4/F18 a atteint le seuil de cinq millions de doses vendues en Union Européenne ( [...]

Onconova Therapeutics to Present at the Disruptive Growth and Healthcare Conference on May 8th, 2018

03/05/2018 - 14:00

NEWTOWN, Pa., May 03, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX ), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with a primary [...]

Pieris Pharmaceuticals to Present at 43rd Annual Deutsche Bank Health Care Conference

03/05/2018 - 14:00

BOSTON, May 03, 2018 (GLOBE NEWSWIRE) -- Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS ) , a biotechnology company advancing novel biotherapeutics through its proprietary Anticalin ® technology platform for cancer, [...]

CASMED to Report First-Quarter 2018 Financial Results and Hold Conference Call on May 10

03/05/2018 - 14:00

BRANFORD, Conn., May 03, 2018 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (NASDAQ: CASM ) (CASMED), a leader in medical devices for non-invasive patient monitoring, announces that it will report financial results for [...]

Athenex, Inc. to Report First Quarter Earnings Results on May 14, 2018

03/05/2018 - 14:00

BUFFALO, N.Y., May 03, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq: ATNX ), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]

T2 Biosystems Reports Granting of Inducement Awards

03/05/2018 - 14:00

LEXINGTON, Mass., May 03, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO ), an emerging leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in [...]

Fibrocell to Host Conference Call and Webcast on Thursday, May 10, 2018 to Discuss First Quarter 2018 Financial Results and Recent Highlights

03/05/2018 - 14:00

EXTON, Pa., May 03, 2018 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ: FCSC ), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, will [...]

VANC Pharmaceuticals’ Vision for a New Future

03/05/2018 - 14:00

VANCOUVER, British Columbia, May 03, 2018 (GLOBE NEWSWIRE) -- VANC Pharmaceuticals Inc. ( “VANC” ) (TSXV:VANC) (OTCQB:NUVPF) Board of Directors provided guidance on future company direction and initiatives today. “In [...]

Opiant Pharmaceuticals To Host Key Opinion Leader Meeting on Medications for Addictions and Related Disorders

03/05/2018 - 14:00

Key Opinion Leader Luncheon to Take Place in New York City on May 10 SANTA MONICA, Calif., May 03, 2018 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. ("Opiant") (NASDAQ: OPNT ), a specialty pharmaceutical company [...]

Caladrius Biosciences to Host First Quarter 2018 Financial Results Conference Call on Thursday, May 10, 2018 at 4:30 p.m. Eastern Time

03/05/2018 - 14:00

BASKING RIDGE, N.J., May 03, 2018 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS ) (“Caladrius” or the “Company”), a development-stage biopharmaceutical company with multiple technology platforms [...]

Catalyst Biosciences Reports First Quarter Operating & Financial Results and Provides Corporate Update

03/05/2018 - 14:00

Announced Korean Ministry of Food and Drug Safety approval to add sixth cohort to the Phase 1/2 trial of CB 2679d/ISU304 in individuals with hemophilia B Raised approximately $106.8 million in an underwritten public [...]

Syneos Health Leaders Honored by the Healthcare Businesswomen’s Association

03/05/2018 - 14:00

RALEIGH, N.C., May 03, 2018 (GLOBE NEWSWIRE) -- Syneos Health™ (Nasdaq: SYNH ), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and CCO (Contract [...]

Key Biologics Accelerates CAR-T Research with New Leukaphereses Offerings

03/05/2018 - 13:45

Also announces installation of Asymptote VIA Quad Freeze controlled-rate freezer MEMPHIS, Tenn. and MONTREAL, May 03, 2018 (GLOBE NEWSWIRE) -- Key Biologics LLC , a provider of biological raw materials and services for [...]

GW Pharmaceuticals to Report Second Quarter Financial Results and Host Conference Call on 8 May, 2018

03/05/2018 - 13:37

LONDON, May 03, 2018 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH ) (“GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its [...]

Strongbridge Biopharma plc Announces New Employment Inducement Awards

03/05/2018 - 13:30

DUBLIN, Ireland and TREVOSE, Pa., May 03, 2018 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP ), a global commercial-stage biopharmaceutical company focused on the development and commercialization of [...]